Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells
- PMID: 15070776
- PMCID: PMC384805
- DOI: 10.1073/pnas.0400420101
Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells
Abstract
The A1-adenosine receptor (A1-AR) is a G protein-coupled receptor that mediates many of the physiological effects of adenosine in the brain, heart, kidney, and adipocytes. Currently, ligand interactions with the A1-AR can be quantified on large cell populations only by using radioligand binding. To increase the resolution of these measurements, we have designed and characterized a previously undescribed fluorescent antagonist for the A1-AR, XAC-BY630, based on xanthine amine congener (XAC). This compound has been used to quantify ligand-receptor binding at a single cell level using fluorescence correlation spectroscopy (FCS). XAC-BY630 was a competitive antagonist of A1-AR-mediated inhibition of cAMP accumulation [log10 of the affinity constant (pKb) = 6.7)] and stimulation of inositol phosphate accumulation (pKb = 6.5). Specific binding of XAC-BY630 to cell surface A1-AR could also be visualized in living Chinese hamster ovary (CHO)-A1 cells by using confocal microscopy. FCS analysis of XAC-BY630 binding to the membrane of CHO-A1 cells revealed three components with diffusion times (tauD) of 62 micros (tauD1, free ligand), 17 ms (tauD2, A1-AR-ligand), and 320 ms (tauD3). Confirmation that tauD2 resulted from diffusion of ligand-receptor complexes came from the similar diffusion time observed for the fluorescent A1-AR-Topaz fusion protein (15 ms). Quantification of tauD2 showed that the number of receptor-ligand complexes increased with increasing free ligand concentration and was decreased by the selective A1-AR antagonist, 8-cyclopentyl-1,3-dipropylxanthine. The combination of FCS with XAC-BY630 will be a powerful tool for the characterization of ligand-A1-AR interactions in single living cells in health and disease.
Figures
References
-
- Ralevic, V. R. & Burnstock, G. (1998) Pharmacol. Rev. 50, 415-475. - PubMed
-
- Klotz, K.-N. (2000) Naunyn-Schmiedeberg's Arch. Pharmacol. 362, 382-391. - PubMed
-
- Cordeaux, Y., Briddon, S. J., Megson, A. E., McDonnell, J., Dickenson, J. M. & Hill, S. J. (2001) Mol. Pharmacol. 58, 1075-1084. - PubMed
-
- Gines, S., Ciruela, F., Burgueno, J., Casado, V., Canela, E. I., Mallol, J., Lluis, C. & Franco, R. (2001) Mol. Pharmacol. 59, 1314-1323. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
